NCT01808989

Brief Summary

The measurement of the transcutaneous oxygen pressure records simultaneously the tcpO2 at the buttocks and chest level during walking. Before and after exercise the diagnosis, investigations and treatments ongoing or to be performed are recorded. The present study focuses on the clinical interest of the transcutaneous oxygen pressure during exercise in the diagnosis of claudication in patient referred for an oximetry exercise test.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
952

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Longer than P75 for all trials

Geographic Reach
1 country

8 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 12, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

October 24, 2022

Status Verified

October 1, 2022

Enrollment Period

8.9 years

First QC Date

March 7, 2013

Last Update Submit

October 20, 2022

Conditions

Keywords

peripheral artery diseasetcpo2treadmill walking testintermittent claudication

Outcome Measures

Primary Outcomes (1)

  • The percentage of patients for whom results tcpO2 effort led to changes in diagnosis measured by the questionnaire filled by the doctor in charge of the patient before and after the test

    during a walk on a treadmill, there is a DROP of tcpo2\<-15

    up to 1 day

Interventions

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with buttock pain and referred for an oximetry exercise test

You may qualify if:

  • referred for an oximetry exercise test
  • Patient able to walk on a treadmill
  • Patient covered by the French health insurance
  • Patient able to understand the protocol
  • Patient agrees to be involve in the protocol and sign the consent form

You may not qualify if:

  • any heart issues during the last 3 months
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University Hospital

Angers, 49933, France

Location

University Hospital

Lille, France

Location

University Hospital

Lomme, France

Location

University Hospital

Marseille, France

Location

University Hospital

Nantes, France

Location

University Hospital

Rennes, France

Location

University Hospital

Toulouse, France

Location

Hospital

Tours, France

Location

MeSH Terms

Conditions

Intermittent ClaudicationPeripheral Arterial Disease

Condition Hierarchy (Ancestors)

Peripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsAtherosclerosisArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Pierre Abraham, MD; PhD

    University hospital, Angers, FRANCE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2013

First Posted

March 12, 2013

Study Start

November 1, 2013

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

October 24, 2022

Record last verified: 2022-10

Locations